147 Patent Results (50 families)
Make Note

Modifiserte Antigen-bindende Molekyler Med Endret Celle-signaliseringsaktivitet

  • Published: May 23, 2008
  • Filed: Mar 13, 2008
  • Earliest Priority: Aug 26 2005
  • Family: 48
  • Cited Works: 0
  • Cited by: 0
  • Cites: 0
  • Additional Info:
  • Applicant: Glycart Biotechnology Ag
Abstract
NO 20081328 L
094-589-750-683-66X

Fusion Constructs And Use Of Same To Produce Antibodies With Increased Fc Receptor Binding Affinity And Effector Function

  • Published: Oct 14, 2014
  • Filed: Feb 5, 2013
  • Earliest Priority: Jan 22 2003
  • Family: 69
  • Cited Works: 93
  • Cited by: 2
  • Cites: 14
  • Sequences: 20
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Roche Glycart Ag, Glycart Biotechnology Ag
  • Applicant: Roche Glycart Ag
Granted Patent
US 8859234 B2
000-352-474-836-176

Predictive Marker For Cancer Treatment

  • Published: Jan 8, 2015
  • Filed: Nov 5, 2013
  • Earliest Priority: Nov 05 2012
  • Family: 2
  • Cited Works: 0
  • Cited by: 0
  • Cites: 0
  • Additional Info: Full text Published
  • Applicant: Hoffmann La Roche, Hoffmann La Roche, Universitaetsklinikum Ulm, Univ Zu Koeln
Patent Application
WO 2014/068133 A8
112-630-159-054-703

Antibody Glycosylation Variants Having Increased Antibody-dependent Cellular Cytotoxicity

  • Published: Apr 7, 2015
  • Filed: Aug 2, 2011
  • Earliest Priority: Aug 03 2001
  • Family: 41
  • Cited Works: 99
  • Cited by: 4
  • Cites: 47
  • Additional Info: Cited Works Full text Published
  • Owner: Roche Glycart Ag, Glycart Biotechnology Ag
  • Applicant: Umaña Pablo, Jean-mairet Joël, Roche Glycart Ag
Granted Patent
US 8999324 B2
134-355-954-155-276

Glycosylation Engineering Of Antibodies For Improving Antibody-dependent Cellular Cytotoxicity

  • Published: Jun 30, 2015
  • Filed: Mar 23, 2009
  • Earliest Priority: Apr 20 1998
  • Family: 45
  • Cited Works: 99
  • Cited by: 4
  • Cites: 47
  • Sequences: 14
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Roche Glycart Ag, Glycart Biotechnology Ag
  • Applicant: Umaña Pablo, Jean-mairet Joël, Bailey M Sean, Roche Glycart Ag
Granted Patent
US 9068005 B2
014-232-128-141-744

Antibodies To Carcinoembryonic Antigen (cea), Methods Of Making Same, And Uses Thereof

  • Published: Jun 30, 2015
  • Filed: Aug 31, 2010
  • Earliest Priority: Aug 31 2009
  • Family: 29
  • Cited Works: 106
  • Cited by: 7
  • Cites: 48
  • Sequences: 215
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Roche Glycart Ag
  • Applicant: Mössner Ekkehard, Hofer Thomas U, Hosse Ralf Jörg, Umaña Pablo, Roche Glycart Ag
Granted Patent
US 9068008 B2
097-770-294-537-524

Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof

  • Published: Jul 7, 2015
  • Filed: Aug 17, 2012
  • Earliest Priority: Aug 09 2006
  • Family: 45
  • Cited Works: 102
  • Cited by: 3
  • Cites: 70
  • Sequences: 147
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Roche Glycart Ag, Glycart Biotechnology Ag
  • Applicant: Umaña Pablo, Mössner Ekkehard, Roche Glycart Ag
Granted Patent
US 9074008 B2
072-087-581-110-749

Glycosylation Engineering Of Antibodies For Improving Antibody-dependent Cellular Cytotoxicity

  • Published: Sep 22, 2015
  • Filed: Dec 23, 2010
  • Earliest Priority: Apr 20 1998
  • Family: 45
  • Cited Works: 99
  • Cited by: 4
  • Cites: 48
  • Sequences: 14
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Roche Glycart Ag, Glycart Biotechnology Ag
  • Applicant: Umaña Pablo, Jean-mairet Joël, Bailey James E, Bailey M Sean, Roche Glyeart Ag
Granted Patent
US 9139654 B2
015-966-800-231-553

Antibody Glycosylation Variants Having Increased Antibody-dependent Cellular Cytotoxicity

  • Published: Oct 1, 2015
  • Filed: Mar 23, 2015
  • Earliest Priority: Aug 03 2001
  • Family: 41
  • Cited Works: 0
  • Cited by: 4
  • Cites: 0
  • Additional Info: Full text
  • Owner: Roche Glycart Ag, Glycart Biotechnology Ag
  • Applicant: Roche Glycart Ag
Patent Application
US 2015/0274837 A1
004-691-882-310-896

Modified Antigen Binding Molecules With Altered Cell Signaling Activity

  • Published: Dec 3, 2015
  • Filed: Dec 19, 2014
  • Earliest Priority: Aug 26 2005
  • Family: 48
  • Cited Works: 0
  • Cited by: 1
  • Cites: 0
  • Sequences: 134
  • Additional Info: Full text Sequence
  • Owner: Roche Glycart Ag, Glycart Biotechnology Ag
  • Applicant: Roche Glycart Ag, Roche Glycart Ag
Patent Application
US 2015/0344584 A1
106-253-852-902-215
{{::'analysis.preview.CITED_WORKS_ANALYSIS.title' | message}} {{::'analysis.preview.view.full' | message}}

Add New Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save
Search ORCID

Sign in to the Lens

Forgot Password? Register New Account
Feedback